ArticleCureus2024
A Case of Catheter-Associated Urinary Tract Infection by Pseudomonas mendocina in the Setting of COVID-19.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudomonas mendocina, a Gram-negative, aerobic bacillus, has rarely been implicated in human infections. This report details the first documented case of catheter-associated urinary tract infection (CAUTI) caused by P. mendocina in a COVID-19-positive patient. We present the case of a 70-year-old male with obstructive uropathy who presented with altered mental status eight days after testing positive for COVID-19. Urine cultures identified P. mendocina and Enterococcus faecalis. The antibiotic regimen was adjusted to cefepime and fosfomycin for coverage against P. mendocina and E. faecalis, respectively, resulting in the patient's improvement and discharge with an outpatient course of ciprofloxacin. However, the patient was readmitted 12 days later for recurrent symptoms and traumatic catheter removal, requiring nephrostomy tube placement. Follow-up revealed severe bladder and prostate abnormalities, confirming a complex interplay of factors contributing to his infection. P. mendocina is a rare opportunistic pathogen, often occurring in patients with pre-existing health conditions. This case is significant as the first CAUTI caused by P. mendocina and highlights potential links between COVID-19 and increased susceptibility to bacterial infections. The patient's comorbidities, particularly obstructive uropathy, and prolonged catheter use, were likely major factors in his infection. The role of COVID-19 in facilitating bacterial colonization remains speculative but warrants further investigation. This case report underscores the need for heightened clinical awareness and prompt intervention in patients with similar risk factors. The successful treatment regimen provides a valuable reference for managing such infections. Further research is needed to explore the interplay between viral and bacterial infections, particularly in the context of COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.